Skip to main content

Nanomedicine: Nanoparticles and Its Relevance in Drug Discovery vis-a-vis Biomedicine

  • Chapter
  • First Online:
Book cover Perspectives in Translational Research in Life Sciences and Biomedicine
  • 452 Accesses

Abstract

Inflammation is a complex response to local injury or other trauma which is characterized by redness, heat, swelling, and pain. Inflammation involves various immune system cells and numerous mediators. Inflammatory process is the net result of a cascade of highly regulated events propagated upon stimulation and is the major process through which the body repairs tissue damage and defends itself against foreign materials. Acute inflammation is typically caused by an external chemical, mechanical, or pathogenic influence; has a relatively short duration; and is a necessary protection tool that removes foreign bodies and damaged tissue, preventing further damage. Aberrant or chronic inflammation requires no external stimulus and can cause a range of painful and debilitating symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stevenson R, Hueber AJ, Hutton A, Graham D. Nanoparticles and inflammation. Sci. World J. 2011;11:1300–12.

    Google Scholar 

  2. Issa B, Obiat IM, Albiss BA, Haik Y. Magnetic nanoparticle. Int. J. Mol. Sci. 2013;14:21266–305.

    Google Scholar 

  3. Friedman AD, Claypool SE. Smart targeting of nanoparticles. Curr. Pharm. Des. 2013;19(35):6315–29.

    Google Scholar 

  4. Metselaar JM, Wauben MHM, Wagenaar-Hilbers JPA, Boerman OC, Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long circulating liposomes. Arthritis Rheum. 2003;48:2059–66.

    Article  CAS  PubMed  Google Scholar 

  5. Richards PJ, Williams AS, Goodfellow RM, Williams BD. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen induced arthritis. Rheumatology. 1999;38:818–25.

    Article  CAS  PubMed  Google Scholar 

  6. Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta. 1995;1237:99–108.

    Article  PubMed  Google Scholar 

  7. Singh R, Lillard Jr JW. Nanoparticles based drug delivery. Exp. Mol. Pathol. 2009;86(3):215–23.

    Google Scholar 

  8. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001;53:283–318.

    CAS  PubMed  Google Scholar 

  9. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug. Del. Rev. 2003;55:329–47.

    Google Scholar 

  10. Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release. 2001;70:353–63.

    Article  CAS  PubMed  Google Scholar 

  11. Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2001;299:775–81.

    CAS  PubMed  Google Scholar 

  12. Fornaguera C, Dols-Perez A, Caldero G, García-Celma M, Camarasa J, Solans C. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier. J. Control. Release. 2015;211:134–43.

    Article  CAS  PubMed  Google Scholar 

  13. Treuel L, Jiang X, Nienhaus GU. New views on cellular uptake. J. Roy. Soc. Interface 2014;10:20120939.

    Google Scholar 

  14. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy. 2005;4(3):281–6.

    Article  CAS  PubMed  Google Scholar 

  15. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19(3):311–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ena Ray Banerjee .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Ray Banerjee, E. (2016). Nanomedicine: Nanoparticles and Its Relevance in Drug Discovery vis-a-vis Biomedicine. In: Perspectives in Translational Research in Life Sciences and Biomedicine. Springer, Singapore. https://doi.org/10.1007/978-981-10-0989-1_16

Download citation

Publish with us

Policies and ethics